Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J LaRocca

Showing results (31-40 of 113) with videos related to

Pageof 12
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 14, 2018
Healthy lifestyle-based approaches for successful vascular agingMatthew J Rossman, Thomas J LaRocca, Christopher R Martens, et al.
Medical Sciences (Basel, Switzerland)|September 26, 2021
Subungual Melanoma: A Single Institution ExperienceChristopher J LaRocca, Lily Lai, Rebecca A Nelson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 1, 2020
Healthy Aging Interventions Reduce Repetitive Element TranscriptsDevin Wahl, Alyssa N Cavalier, Meghan Smith, et al.
Clinical Pharmacy|October 1, 1988
Postinfusion phlebitis after intravenous push versus intravenous piggyback administration of antimicrobial agentsJ C Garrelts, D Ast, J LaRocca, et al.
Clinical Pharmacy|January 1, 1989
Comparison of heparin and 0.9% sodium chloride injection in the maintenance of indwelling intermittent i.v. devicesJ C Garrelts, J LaRocca, D Ast, et al.
Mechanisms of Ageing and Development|April 25, 2013
The autophagy enhancer spermidine reverses arterial agingThomas J LaRocca, Rachel A Gioscia-Ryan, Christopher M Hearon, et al.
Physiology (Bethesda, Md.)|July 3, 2014
You're only as old as your arteries: translational strategies for preserving vascular endothelial function with agingDouglas R Seals, Rachelle E Kaplon, Rachel A Gioscia-Ryan, et al.
Molecular Therapy Oncolytics|May 14, 2019
Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both WorldsVenkatesh Sivanandam, Christopher J LaRocca, Nanhai G Chen, et al.
Viruses|April 27, 2024
Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem CellsSacha Robert, Natasha Ivelisse Roman Ortiz, Christopher J LaRocca, et al.
Oncotarget|May 3, 2018
Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancerAmanda O Salzwedel, Joohee Han, Christopher J LaRocca, et al.
Pageof 12

Showing results (31-40 of 113) with videos related to

Sort By:
Pageof 12
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 14, 2018
Healthy lifestyle-based approaches for successful vascular agingMatthew J Rossman, Thomas J LaRocca, Christopher R Martens, et al.
Medical Sciences (Basel, Switzerland)|September 26, 2021
Subungual Melanoma: A Single Institution ExperienceChristopher J LaRocca, Lily Lai, Rebecca A Nelson, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 1, 2020
Healthy Aging Interventions Reduce Repetitive Element TranscriptsDevin Wahl, Alyssa N Cavalier, Meghan Smith, et al.
Clinical Pharmacy|October 1, 1988
Postinfusion phlebitis after intravenous push versus intravenous piggyback administration of antimicrobial agentsJ C Garrelts, D Ast, J LaRocca, et al.
Clinical Pharmacy|January 1, 1989
Comparison of heparin and 0.9% sodium chloride injection in the maintenance of indwelling intermittent i.v. devicesJ C Garrelts, J LaRocca, D Ast, et al.
Mechanisms of Ageing and Development|April 25, 2013
The autophagy enhancer spermidine reverses arterial agingThomas J LaRocca, Rachel A Gioscia-Ryan, Christopher M Hearon, et al.
Physiology (Bethesda, Md.)|July 3, 2014
You're only as old as your arteries: translational strategies for preserving vascular endothelial function with agingDouglas R Seals, Rachelle E Kaplon, Rachel A Gioscia-Ryan, et al.
Molecular Therapy Oncolytics|May 14, 2019
Oncolytic Viruses and Immune Checkpoint Inhibition: The Best of Both WorldsVenkatesh Sivanandam, Christopher J LaRocca, Nanhai G Chen, et al.
Viruses|April 27, 2024
Oncolytic Adenovirus for the Targeting of Paclitaxel-Resistant Breast Cancer Stem CellsSacha Robert, Natasha Ivelisse Roman Ortiz, Christopher J LaRocca, et al.
Oncotarget|May 3, 2018
Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancerAmanda O Salzwedel, Joohee Han, Christopher J LaRocca, et al.
Pageof 12